RCAMU
CNMD icon

Rothschild & Co Asset Management US’s CONMED CNMD Stock Holding History

Rothschild & Co Asset Management US’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-50,879
Closed -$4.35M – 352
2019
Q2 		$4.35M Sell
50,879
-3,888
-7% -$320K 0.05% 286
2019
Q1 		$4.56M Buy
54,767
+206
+0.4% +$15K 0.05% 292
2018
Q4 		$3.5M Sell
54,561
-197
-0.4% -$13.5K 0.04% 307
2018
Q3 		$4.34M Sell
54,758
-2,013
-4% -$156K 0.04% 310
2018
Q2 		$4.16M Sell
56,771
-2,236
-4% -$152K 0.04% 307
2018
Q1 		$3.74M Sell
59,007
-6,158
-9% -$368K 0.04% 300
2017
Q4 		$3.32M Buy
65,165
+11,444
+21% +$596K 0.04% 298
2017
Q3 		$2.82M Buy
53,721
+18,489
+52% +$928K 0.03% 296
2017
Q2 		$1.79M Buy
35,232
+107
+0.3% +$5.29K 0.02% 330
2017
Q1 		$1.56M Sell
35,125
-1,484
-4% -$63.8K 0.02% 341
2016
Q4 		$1.62M Buy
36,609
+2,165
+6% +$92K 0.02% 353
2016
Q3 		$1.38M Buy
34,444
+101
+0.3% +$4.29K 0.02% 333
2016
Q2 		$1.64M Buy
34,343
+2,785
+9% +$118K 0.03% 329
2016
Q1 		$1.32M Sell
31,558
-74,626
-70% -$2.93M 0.02% 309
2015
Q4 		$4.68M Buy
106,184
+11,287
+12% +$490K 0.09% 272
2015
Q3 		$4.53M Sell
94,897
-2,015
-2% -$111K 0.09% 264
2015
Q2 		$5.65M Buy
96,912
+550
+0.6% +$29.7K 0.1% 253
2015
Q1 		$4.87M Sell
96,362
-5,763
-6% -$282K 0.09% 269
2014
Q4 		$4.59M Sell
102,125
-970
-0.9% -$40.7K 0.09% 266
2014
Q3 		$3.8M Sell
103,095
-76,112
-42% -$3.02M 0.08% 281
2014
Q2 		$7.91M Sell
179,207
-3,617
-2% -$164K 0.16% 211
2014
Q1 		$7.94M Sell
182,824
-17,188
-9% -$766K 0.18% 208
2013
Q4 		$8.5M Sell
200,012
-15,561
-7% -$591K 0.19% 196
2013
Q3 		$7.32M Sell
215,573
-22,965
-10% -$749K 0.16% 218
2013
Q2 		$7.45M Buy
+238,538
New +$7.74M 0.17% 195

Other funds holding CNMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Rothschild & Co Asset Management US's CNMD Position: Q3 2019 in Review

Rothschild & Co Asset Management US sold out of CONMED (CNMD) in Q3 2019, closing a stake of 50,879 shares — an estimated $4.35M sold.

Rothschild & Co Asset Management US first reported a position in CNMD in Q2 2013 and held it in 25 quarters. The position peaked at $8.5M in Q4 2013. 234 funds tracked by Wall St. Rank hold CNMD as of Q3 2019.

  • Rothschild & Co Asset Management US reported no remaining CONMED position as of Q3 2019 after selling out during the quarter.
  • Rothschild & Co Asset Management US sold 50,879 CONMED shares in Q3 2019, an estimated $4.35M.
  • Rothschild & Co Asset Management US first reported a position in CONMED in Q2 2013 and held it in 25 quarters.
  • Rothschild & Co Asset Management US's CONMED position peaked at $8.5M in Q4 2013.
  • 234 funds tracked by Wall St. Rank held CONMED as of Q3 2019.

Based on Rothschild & Co Asset Management US's 13F filing for Q3 2019, filed 8 Nov 2019.